Soteropoulos Paula — SEC insider filings

SEC reporting owner CIK 1692444. 24 insider filings on record with FilingPulse; latest filed 2026-10-20.

Transaction summary — filings shown

Covers all 24 filings on record, filed 2021-03-01 to 2026-10-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Dianthus Therapeutics, Inc. /DE/ (DNTH)Director7—3 legs · 28,792 sh · $2,252,89410
uniQure N.V. (QURE)Director11—9 legs · 24,979 sh · $543,56616
Rallybio Corp (RLYB)Director6——7

Insider filings — Soteropoulos Paula

FiledFormIssuerReported transactionsSource
2026-10-204Rallybio Corp (RLYB)Option exercise (M): 3,562 @ $2.38 · Option exercise (M): 3,562 (derivative) @ $0EDGAR
2026-05-224Dianthus Therapeutics, Inc. /DE/ (DNTH)Grant/award (A): 6,090 (derivative) @ $0EDGAR
2026-05-114Dianthus Therapeutics, Inc. /DE/ (DNTH)Option exercise (M): 599 @ $8.44 · Sale (S): 599 @ $85.47 · Option exercise (M): 599 (derivative) @ $0EDGAR
2026-04-014Dianthus Therapeutics, Inc. /DE/ (DNTH)Option exercise (M): 599 @ $8.44 · Sale (S): 599 @ $80.11 · Option exercise (M): 599 (derivative) @ $0EDGAR
2026-03-264Dianthus Therapeutics, Inc. /DE/ (DNTH)Option exercise (M): 27,594 @ $8.44 · Sale (S): 27,594 @ $78.05 · Option exercise (M): 27,594 (derivative) @ $0EDGAR
2025-05-224Dianthus Therapeutics, Inc. /DE/ (DNTH)Grant/award (A): 12,500 (derivative) @ $0EDGAR
2025-05-154Rallybio Corp (RLYB)Grant/award (A): 28,500 (derivative) @ $0EDGAR
2024-06-174uniQure N.V. (QURE)Sale (S): 2,220 @ $5.14EDGAR
2024-05-284Dianthus Therapeutics, Inc. /DE/ (DNTH)Grant/award (A): 11,000 (derivative) @ $0EDGAR
2024-05-174Rallybio Corp (RLYB)Grant/award (A): 16,500 (derivative) @ $0EDGAR
2023-09-134Dianthus Therapeutics, Inc. /DE/ (DNTH)Grant/award (A): 6,500 (derivative) @ $0EDGAR
2023-06-204uniQure N.V. (QURE)Grant/award (A): 8,700 @ $0 · Sale (S): 2,275 @ $18.99 · Grant/award (A): 17,060 (derivative) @ $0EDGAR
2023-05-194Rallybio Corp (RLYB)Grant/award (A): 15,490 (derivative) @ $0EDGAR
2023-03-014uniQure N.V. (QURE)Sale (S): 384 @ $19.97EDGAR
2023-01-204uniQure N.V. (QURE)Option exercise (M): 6,000 @ $5.37 · Sale (S): 6,000 @ $22.59 · Option exercise (M): 6,000 (derivative) @ $0EDGAR
2022-12-154uniQure N.V. (QURE)Option exercise (M): 3,000 @ $5.37 · Sale (S): 3,000 @ $23.45 · Option exercise (M): 3,800 · Sale (S): 3,800 @ $23.43 · Option exercise (M): 3,000 (derivative) @ $0 · Option exercise (M): 3,800 (derivative) @ $0EDGAR
2022-12-014uniQure N.V. (QURE)Option exercise (M): 6,200 · Sale (S): 6,200 @ $25.38 · Option exercise (M): 6,200 (derivative) @ $0EDGAR
2022-06-174uniQure N.V. (QURE)Grant/award (A): 9,080 @ $0 · Grant/award (A): 17,810 (derivative) @ $0EDGAR
2022-05-264Rallybio Corp (RLYB)Grant/award (A): 13,440 (derivative) @ $0EDGAR
2022-03-024uniQure N.V. (QURE)Sale (S): 596 @ $16.87EDGAR
2022-02-284uniQure N.V. (QURE)Grant/award (A): 1,534 @ $0 · Grant/award (A): 2,645 (derivative) @ $0EDGAR
2022-01-054Rallybio Corp (RLYB)Grant/award (A): 5,369 (derivative) @ $0EDGAR
2021-03-044uniQure N.V. (QURE)Sale (S): 504 @ $37.60EDGAR
2021-03-014uniQure N.V. (QURE)Grant/award (A): 2,382 @ $0 · Grant/award (A): 4,107 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-02-25 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1692444 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs